Literature DB >> 11210941

Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase.

K I Pfrepper1, J Reed, H R Rackwitz, M Schnölzer, R M Flügel.   

Abstract

Oligopeptides that correspond to proteolytic cleavage site junctions of the native Gag and Pol proteins are specifically cleaved by retroviral aspartate proteases (PRs). The role of the flap subdomain of the PR of the human spumaretrovirus (HSRV) and of substrate peptides in cleavage site specificity was analyzed by site-directed mutagenesis. Native and mutant peptides were subjected to proteolysis by the authentic and mutated recombinant viral enzyme. The results reveal that Glu residue 54 of the HSRV PR is an essential specificity determinant for proteolytic processing of the structural proteins. Peptides that represent in vivo cleavage sites were susceptible to proteolysis by the recombinant HSRV PR, but one peptide located at the junction between the PR and reverse transcriptase domains was completely resistant to cleavage. Thus the data indicate that a proteolytic cleavage between these domains does not occur in vivo. Naturally occurring and mutant forms of the cleavage-resistant peptide were therefore analyzed by circular dichroism to determine if differences existed in the secondary structures of the peptides that did or did not serve as substrates. The data show that differences in the secondary structure of the native and mutant peptides analyzed does not seem to play a crucial role for cleavage site specificity in HSRV PR. Instead highly conserved hydrophobic residues at distinct positions of the HSRV cleavage site junctions contribute to the specificity observed as reported for HIV-1 PR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11210941     DOI: 10.1023/a:1008134419542

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  22 in total

1.  Expression and characterization of human foamy virus proteinase.

Authors:  G Fenyöfalvi; P Bagossi; T D Copeland; S Oroszlan; P Boross; J Tözsér
Journal:  FEBS Lett       Date:  1999-12-03       Impact factor: 4.124

2.  Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases.

Authors:  J K Rao; J W Erickson; A Wlodawer
Journal:  Biochemistry       Date:  1991-05-14       Impact factor: 3.162

3.  A set of constructed type spectra for the practical estimation of peptide secondary structure from circular dichroism.

Authors:  J Reed; T A Reed
Journal:  Anal Biochem       Date:  1997-12-01       Impact factor: 3.365

4.  Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease.

Authors:  K I Pfrepper; M Löchelt; M Schnölzer; R M Flügel
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

5.  Synthetic peptides as substrates and inhibitors of a retroviral protease.

Authors:  M Kotler; R A Katz; W Danho; J Leis; A M Skalka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.

Authors:  J Konvalinka; M Löchelt; H Zentgraf; R M Flügel; H G Kräusslich
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Structure of equine infectious anemia virus proteinase complexed with an inhibitor.

Authors:  A Gustchina; J Kervinen; D J Powell; A Zdanov; J Kay; A Wlodawer
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

8.  Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease.

Authors:  K I Pfrepper; H R Rackwitz; M Schnölzer; H Heid; M Löchelt; R M Flügel
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein.

Authors:  M Löchelt; R M Flügel
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.

Authors:  M D Moody; S C Pettit; W Shao; L Everitt; D D Loeb; C A Hutchison; R Swanstrom
Journal:  Virology       Date:  1995-03-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.